RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 67-77
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • NIH: Herpes vaccine doesn't help women

    NIH: Herpes vaccine doesn't help women
    (Reuters) - GlaxoSmithKline's herpes vaccine failed to protect women against the virus in a trial, the U.S. National Institutes of Health said Thursday, and the company said it was stopping development of the product. The test of 8,000 women in the U.S....
  • Expectations affect benefits of pain drug

    Expectations affect benefits of pain drug
    People who don't believe their pain medicine will work can actually reduce or even cancel out the effectiveness of the drug, and images of their brains show how they are doing it, scientists report. Researchers from Britain and Germany used brain scans...
  • Cancer study boosts hopes for Roche's armed antibody

    Cancer study boosts hopes for Roche's armed antibody
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • Dangerous pharmaceuticals marketed as supplements

    Dangerous pharmaceuticals marketed as supplements
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...
  • Doctors draw payments from drug companies

    Doctors draw payments from drug companies
    Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of...
  • Doctor-drug company database adds to confusion for consumers

    Doctor-drug company database adds to confusion for consumers
    Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues. He found several doctors who had potentially compromising...
  • Antidepressants and pregnancy

    Antidepressants and pregnancy
    Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants? Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
  • GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
  • Claim: PA taxpayers footed $234K bill for "corporate front group" that pushes legislation.

     
    Liberal advocacy groups are stepping up their attacks on the American Legislative Exchange Council (ALEC), charging this week that the think-tank has been the recipient of tens of thousands of dollars in Pennsylvania taxpayers' money. Citing documents...